Terenius, 1973 - Google Patents
Estrogen and progestogen binders in human and rat mammary carcinomaTerenius, 1973
- Document ID
- 3344632316252110936
- Author
- Terenius L
- Publication year
- Publication venue
- European Journal of Cancer (1965)
External Links
Snippet
Estrogen and progestogen binders (so-called receptors) were measured in the high speed ultracentrifugal supernatant (cytosol) from 23 samples of human mammary carcinoma. Estrogen receptors were also measured in slices in 15 of these tumors. With one notable …
- 239000000583 progesterone congener 0 title abstract description 34
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Terenius | Estrogen and progestogen binders in human and rat mammary carcinoma | |
Pichon et al. | Characterization and assay of progesterone receptor in human mammary carcinoma | |
Lippman et al. | The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture | |
Korenman | Comparative binding affinity of estrogens and its relation to estrogenic potency | |
King et al. | Effect of estrogen and progestin treatments on endometria from postmenopausal women | |
Lindner et al. | Steroids in the ovarian lymph and blood of conscious ewes | |
LUCAS | Causal relationships between endocrine-metabolic variables in patients with endometrial carcinoma | |
Cowan et al. | Binding of methyltrienolone (R1881) to a progesterone receptor-like component of human prostatic cytosol | |
OTTOSON et al. | Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration | |
GIANNOPOULOS et al. | Cytoplasmic and nuclear progestin receptors in human myometrium during the menstrual cycle and in pregnancy at term | |
Barnes et al. | Two methods for measurement of oestradiol-17β and progesterone receptors in human breast cancer and correlation with response to treatment | |
Screpanti et al. | The fetal thymus of guinea pig as an estrogen target organ | |
Li et al. | Receptor characteristics of specific estrogen binding in the renal adenocarcinoma of the golden hamster | |
Sirett et al. | Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue | |
Bhakoo et al. | High incidence and characterization of glucocorticoid receptors in human malignant melanoma | |
Kokko et al. | Danazol has progestin-like actions on the human endometrium | |
Zava et al. | Estrogen receptors in androgen-induced breast tumor regression | |
McGuire et al. | A physiological role for estrogen and progesterone in breast cancer | |
Schleicher et al. | Inhibition of hamster melanoma growth by estrogen | |
Cerbon et al. | Thyroid hormone receptors in human breast cancer | |
Scharl et al. | Immunohistochemical study of distribution of estrogen receptors in corpus and cervix uteri | |
Pewnim et al. | A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma | |
Schenker et al. | Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer | |
Biro et al. | Inhibitory effect of the uterus on plasma and pituitary FSH in rats | |
VERHAGE et al. | Cyclic changes in cytosol progesterone receptor of human fallopian tube |